BioSpace News Archive

CVS Health Corporation announced that Neela Montgomery has been named Executive Vice President and President of CVS Pharmacy/Retail, effective November 30, 2020.

Partnership will use AI to match patients with the best treatments based on their biological profiles. Work in Florida will serve as a model for the rest of the USA

Taiho Oncology, Inc. today announced that the FDA approved hypomethylating agent INQOVI® (decitabine and cedazuridine) 35 mg/100 mg tablets, for oral use, has been included in the latest National Comprehensive Cancer Network® Clinical Practice Guidelines (NCCN Guidelines®) in Oncology for Myelodysplastic Syndromes (MDS).

- Company aims to apply machine learning to large datasets created by this study to identify approaches to increase patient response to existing oncology treatments as well as identify new therapeutic targets - - Planned enrollment of 4,000 patients makes ARGONAUT the largest ever clinical study to map the cancer gut microbiome immune axis in the U.S. -

Neurelis, Inc., announced today that it has concluded a pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA) regarding NRL-4.

AliveCor , the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced that the US FDA had given clearance to the company’s next generation of interpretive ECG algorit

Brightseed, developer of Forager® AI, and Pharmavite LLC, a leader in the health and wellness industry and the makers of Nature Made® vitamins, today announced a new partnership to identify phytonutrients that are currently undiscovered in the plant kingdom.

MouthWatch, LLC, a leader in innovative teledentistry solutions, digital case presentation tools and intraoral imaging devices, recently published a highly relevant whitepaper entitled, “Teledentistry: Post-COVID-19 Use for Safe, Efficient and Evidence-Based Care.”

Nuvaira , a developer of novel therapeutic strategies to treat obstructive lung diseases, announced today publication of two-year follow-up data from its randomized, sham-controlled, double-blinded tri

VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter monitoring.